title: Duration of immunity and efficacy of an oil emulsion Escherichia coli bacterin in cattle.
abstract: An oil emulsion Escherichia coli bacterin administered in 1- and 2-dose vaccination regimens was evaluated in beef cattle. Serologic responses to the K99 pilus antigen were monitored, and suckling offspring from vaccinated and nonvaccinated cows were inoculated with virulent, K99-positive, enterotoxigenic Escherichia coli. The degree of protection and duration of immunity conferred were determined in 2 respective studies. In the first study (study A), titers of pregnant cattle were determined from time of vaccination through calving (a 6- to 20-week period). Titers of 24 cows vaccinated with a single 2-ml dose of bacterin were compared with those of 24 cows given a 2-dose regimen and with those of 23 nonvaccinated cattle (contemporary controls). Inoculum consisting of 1.2 X 10(12) viable enterotoxigenic E coli/dose administered to nursing calves from these dams yielded 0% mortality (0 deaths/20 calves) in calves from 1-dose vaccinates, 6% mortality (1 death/18 calves) in calves from 2-dose vaccinates, and 37% mortality (7 deaths/19 calves) in calves from nonvaccinated dams. Study B was an extended evaluation conducted in cattle that were kept in the study up to 87 weeks from initial vaccination until calving. Serologic titers to the K99 pilus antigen were compared in 1-dose, 2-dose, and nonvaccinated cattle in groups of 8, 6, and 6, respectively. Calves from these dams were inoculated with 8.1 X 10(11) viable enterotoxigenic E coli/dose, which resulted in 0% mortality (0 deaths/5 calves) in calves from 1-dose vaccinates, 0% mortality (0 deaths/5 calves) in calves from 2-dose vaccinates, and 80% mortality (5 deaths/6 calves) in calves from nonvaccinated dams.
authors.affiliation: Department of Research and Development, Grand Laboratories, Inc., Larchwood, IA 51241.
authors.forename: N F
authors.initials: NF
authors.lastname: Collins
authors.forename: T
authors.initials: T
authors.lastname: Halbur
authors.forename: W H
authors.initials: WH
authors.lastname: Schwenck
authors.forename: P
authors.initials: P
authors.lastname: Hoogeveen
authors.forename: R L
authors.initials: RL
authors.lastname: Pierce
authors.forename: R W
authors.initials: RW
authors.lastname: Behan
authors.forename: D
authors.initials: D
authors.lastname: Pankratz
mesh_terms: D000277:Adjuvants, Pharmaceutic; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis*; D001428:Bacterial Vaccines / Q000276:immunology*; D002417:Cattle / Q000276:immunology*; D004341:Drug Evaluation / Q000662:veterinary; D004655:Emulsions; D004926:Escherichia coli / Q000276:immunology*; D022361:Escherichia coli Vaccines; D005260:Female
chemical_list: D000277:Adjuvants, Pharmaceutic; D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D004655:Emulsions; D022361:Escherichia coli Vaccines